Review
Accepted on 16 Jan 2025
Research Progress of Hypoxia-Inducible Factor-1α and Zinc in the Mechanism of Diabetic Kidney Disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1537749
Type at least 3 characters
595 articles
Articles
Review
Published on 14 Jan 2025
Current status and prospects of traditional Chinese medicine combined with stem cell therapy for chronic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1505206
- 174 views
Original Research
Published on 13 Jan 2025
Danshen injection ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibiting ferroptosis via activating SIRT1/GPX4 pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1503628
- 236 views
Review
Published on 13 Jan 2025
Ferroptosis in kidney disease: a bibliometric analysis from 2012 to 2024
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1507574
- 232 views
Original Research
Accepted on 10 Jan 2025
Impact of Cordyceps Sinensis on Coronary Computed Tomography Angiography Image Quality and Renal Function in a Beagle Model of Renal Impairment
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1538916
Original Research
Accepted on 09 Jan 2025
Integrated Serum Metabolomics and Network Pharmacology reveal molecular mechanism of Qixue Huazheng Formula on Peritoneal Fibrosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1515038
Original Research
Published on 09 Jan 2025
Safety assessment of tolvaptan: real-world adverse event analysis using the FAERS database
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1509310
- 260 views
Original Research
Published on 07 Jan 2025
Research hotspots and frontiers of endoplasmic reticulum in glomerular podocytes: a bibliometric and visual analysis from 2005 to 2023
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1488340
- 166 views
Review
Published on 07 Jan 2025
Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1475198
- 187 views
Original Research
Published on 07 Jan 2025
High mobility group box 1 (HMGB1) mediates nicotine-induced podocyte injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1540639
- 424 views
Review
Accepted on 06 Jan 2025
Baicalin: a potential therapeutic agent for acute kidney injury and renal fibrosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1511083
Correction
Published on 06 Jan 2025
Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1548193
- 310 views
Original Research
Published on 06 Jan 2025
The efficacy and safety of half-dose glucocorticoids combined with rituximab versus high-dose glucocorticoids for initial treatment of minimal change disease: a single-center experience
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1403562
- 135 views
Original Research
Published on 06 Jan 2025
Curcumin nanocrystals ameliorate ferroptosis of diabetic nephropathy through glutathione peroxidase 4
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1508312
- 107 views
Systematic Review
Published on 03 Jan 2025
Protective effects and possible mechanisms of mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles against kidney fibrosis in animal models: a systematic review and meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1511525
- 150 views
Original Research
Published on 03 Jan 2025
FGF21 ameliorates diabetic nephropathy through CDK1-dependently regulating the cell cycle
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1500458
- 169 views